Table 3 Summary of molecular aberrations per tumor type
Vaginal cancer, n (%) | Vulvar cancer, n (%) | |
|---|---|---|
PIK3CA | 33 % (n = 9) | 0 % (n = 8) |
PTEN | 67 % (n = 6) | 0 % (n = 4) |
KRAS | 10 % (n = 10) | 13 % (n = 8) |
NRAS | 10 % (n = 10) | 0 % (n = 4) |
EGFR | 0 % (n = 9) | 0 % (n = 6) |
BRAF | 0 % (n = 9) | 14 % (n = 7) |
C-MET | 0 % (n = 7) | 0 % (n = 3) |
TP53 | 0 % (n = 6) | 33 % (n = 3) |
C-KIT | 0 % (n = 8) | 20 % (n = 3) |